Showing results (131-140 of 152) with videos related to
Sort By:
Pageof 16
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|January 23, 2003
Cytokine and adhesion molecule expression in primary human endothelial cells stimulated with fever-range hyperthermiaA Shah, E Unger, M D Bain, et al.Blood|June 15, 1991
Identification and comparison of CD34-positive cells and their subpopulations from normal peripheral blood and bone marrow using multicolor flow cytometryJ G Bender, K L Unverzagt, D E Walker, et al.Laboratory Investigation; a Journal of Technical Methods and Pathology|March 1, 1990
Acute endotoxin-induced lymphocyte subset sequestration in sheep lungsS S Duke, M L Guerry-Force, J T Forbes, et al.Nanotechnology|April 4, 2013
Alternative low-cost approach to the synthesis of magnetic iron oxide nanoparticles by thermal decomposition of organic precursorsI O Perez De Berti, M V Cagnoli, G Pecchi, et al.Journal of Nanoscience and Nanotechnology|May 15, 2009
The formation of nanocrystalline SrFeO(3-delta) using mechano-synthesis and subsequent sintering: structural and Mössbauer studiesH M Widatallah, A D Al-Rawas, C Johnson, et al.Cancer Research|July 15, 1994
p185c-erbB-2 signal enhances cisplatin-induced cytotoxicity in human breast carcinoma cells: association between an oncogenic receptor tyrosine kinase and drug-induced DNA repairC L Arteaga, A R Winnier, M C Poirier, et al.Leukemia|April 12, 2003
HLA-DR antigen-negative acute myeloid leukemiaM Wetzler, B K McElwain, C C Stewart, et al.Leukemia|April 7, 1998
Acute myeloid leukemia with 11q23 translocations: myelomonocytic immunophenotype by multiparameter flow cytometryM R Baer, C C Stewart, D Lawrence, et al.Journal of Leukocyte Biology|December 1, 1986
Comparison of five short-term assays that measure nonspecific cytotoxicity mediated to tumor cells by activated macrophagesS W Russell, J L Pace, L Varesio, et al.Blood|November 1, 1995
Prolonged administration of low-dose interleukin-2 in human immunodeficiency virus-associated malignancy results in selective expansion of innate immune effectors without significant clinical toxicityZ P Bernstein, M M Porter, M Gould, et al.Pageof 16